• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “An overview of immune checkpoint inhibitors in breast cancer”.
    No. Publication Date Citing Article
    1 2023 Alia Aldahlawi, Fatemah Basingab, Jehan Alrahimi, Kawther Zaher, Peter Pushparaj, Mohammed Hassan, Kaltoom Al‑sakkaf. Herpesvirus entry mediator as a potential biomarker in breast cancer compared with conventional cytotoxic T‑lymphocyte‑associated antigen 4, Biomedical Reports. 2023; 19: 56.  https://doi.org/10.3892/br.2023.1638
    2 2021 Federica Miglietta, Maria Vittoria Dieci, Gaia Griguolo, Valentina Guarneri. Neoadjuvant approach as a platform for treatment personalization: focus on HER2-positive and triple-negative breast cancer, Cancer Treatment Reviews. 2021; 98: 102222102222.  https://doi.org/10.1016/j.ctrv.2021.102222
    3 2023 María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Silvia Silva Romeiro, Carmen Garnacho, Luis de la Cruz-Merino, Daniel J. García-Domínguez, Lourdes Hontecillas-Prieto, Víctor Sánchez-Margalet. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells, International Journal of Molecular Sciences. 2023; 24: 5208.  https://doi.org/10.3390/ijms24065208
    4 2023 Sharat Chopra, Muskaan Khosla, Raghavan Vidya. Innovations and Challenges in Breast Cancer Care: A Review, Medicina. 2023; 59: 957.  https://doi.org/10.3390/medicina59050957